SCHEMBL18859608

SCHEMBL18859608

c1ccc(-c2c3ccccc3c(-c3cccc(-c4nc5sc6ccccc6c5c5ccccc45)c3)c3ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 1/20 0.34
▸ ESR1 P03372 3/20 0.34
▸ ESR2 Q92731 3/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ ADORA2A P29274 4/20 0.33
▸ PTPN1 P18031 1/20 0.33
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ ADORA1 P30542 1/20 0.31
▸ GPR3 P46089 1/20 0.31
▸ NQO1 P15559 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18803208 0.85 ELANE (0.40) ELANEKDM4EMAPTADORA2ACYP1A2
SCHEMBL18370864 0.85 ADORA2A (0.36) ELANEESR1ESR2KDM4EL3MBTL1
SCHEMBL18859601 0.84 ELANE (0.36) ELANEESR1ESR2KDM4EMAPT
SCHEMBL18859604 0.84 ELANE (0.34) ELANEMAPTADORA2AALDH1A1HPGD
SCHEMBL18370861 0.83 ADORA2A (0.36) ELANEESR1ESR2KDM4EL3MBTL1
SCHEMBL18859681 0.83 GPR3 (0.37) ELANEMAPTCYP1A2ALDH1A1HPGD
SCHEMBL18859611 0.83 F9 (0.37) ELANEKDM4EL3MBTL1MAPTMAPK1
SCHEMBL18859614 0.83 HSD17B1 (0.39) ELANEESR1ESR2KDM4EMAPT
SCHEMBL18859662 0.83 ELANE (0.34) ELANEKDM4EMAPTADORA2AADORA1
SCHEMBL21032416 0.82 ESR1 (0.44) ELANEESR1ESR2KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10644244-B2 Heterocyclic compound and organic light emitting device using same LT MATERIALS CO., LTD. (KR) 2020-05-05 — — US disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, CRY2, CYBA ELANE 4401/4885ESR1 155/4885ESR2 830/4885
US-10644244-B2 Heterocyclic compound and organic light emitting device using same CRY1, CRY2, CYBA ELANE 4401/4885ESR1 155/4885ESR2 830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback